MedTrace Logo

COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) Risk / World Health Organization (WHO)

NCT06255860 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 204

Last updated 2024-11-21

No results posted yet for this study

Summary

This study is a multicenter, international, non interventional, retrospective study about SARS-CoV-2 and Multisystem Inflammatory Syndrome (MIS-C) reinfection risk in children.

Conditions

Sponsors & Collaborators

  • Association Clinique Thérapeutique Infantile du val de Marne

    lead OTHER

Principal Investigators

  • Corinne Levy, Physician · Association Clinique Thérapeutique Infantile du val de Marne

  • Naim Ouldali, Physician · Hôpital Robert Debré AP-HP, Paris 19

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-22
Primary Completion
2024-04-01
Completion
2024-04-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06255860 on ClinicalTrials.gov